Open Access Government presents the policies of the Icelandic Ministry of the Environment, Energy, and Climate, which develops and enforces government policy on environmental issues.
The Horizon Europe Cluster 4 Industry calls continue to show strong engagement from Europe’s research and innovation community, with more than 800 proposals evaluated across single-stage and two-stage calls.
Cecilia Van Cauwenberghe explains how to measure the future using nanoscale metrology and discusses the global competition for technological superiority.
The NHS will prioritise menopause and prostate problems in its new digital hospital service, giving patients faster access to specialist care via the NHS App and remote consultations when the service launches in 2027.
NICE recommends natalizumab, including a lower-cost biosimilar, as a new treatment for adults with highly active relapsing-remitting multiple sclerosis, expanding options for thousands of patients.
The UK bioscience innovation community will come together again in spring 2026 as the Biotechnology and Biological Sciences Research Council (BBSRC) announces the return of its flagship Sparking Innovation Conference.
University of Sheffield researchers helped secure FDA approval for a new bone imaging method that could speed up osteoporosis drug trials, meaning new treatments may reach patients faster than ever.
As artificial intelligence continues to embed itself in the most important sectors, including healthcare, manufacturing, and mobility, concerns about cybersecurity and system resilience are growing just as quickly.
New Oxford University research reveals NHS England spends around 3% of its primary and secondary care budget, roughly £3 billion, on illnesses linked to extreme temperatures.
Karl Knox, Head of Business, Management, and Commerce at Ravensbourne University London, discusses how to future-proof Europe’s finance and business leaders through aligned education, policy and industry.
Hospitals across England are increasingly turning to artificial intelligence to reduce pressure on accident and emergency departments, helping patients receive faster care during one of the busiest times of the year.
Asal Shirazi BEM, the Founder and CEO of ASA Foundation, shares insights into how inflammatory mechanisms drive autoimmunity and highlights the role of environmental toxins, along with effective strategies to mitigate their impact.
